212:
420:
29:
327:
InChI=1S/C34H41N3O7/c1-41-29-20-26(21-30(42-2)32(29)43-3)31(38)33(39)37-19-5-4-16-28(37)34(40)44-27(14-6-10-24-12-8-17-35-22-24)15-7-11-25-13-9-18-36-23-25/h8-9,12-13,17-18,20-23,27-28H,4-7,10-11,14-16,19H2,1-3H3/t28-/m0/s1
285:
497:
41:
468:
299:
487:
461:
454:
362:
319:
65:
492:
151:
191:
395:
400:
374:
180:
405:
207:
434:
86:
140:
228:
95:
160:
431:
211:
438:
427:
378:
481:
120:
419:
390:
370:
261:
131:
20:
106:
307:
O=C(C(=O)c1cc(OC)c(OC)c(OC)c1)N4(C(=O)OC(CCCc2cccnc2)CCCc3cccnc3)CCCC4
28:
171:
284:
275:
196:
442:
344:
273:
260:
227:
222:
190:
170:
150:
130:
105:
85:
56:
40:
35:
119:
94:
498:Antineoplastic and immunomodulating drug stubs
462:
8:
19:
469:
455:
210:
139:
27:
381:patients, that never reached the market.
159:
324:
304:
206:
70:
18:
179:
7:
416:
414:
110:
73:1,7-di(pyridin-3-yl)heptan-4-yl (2
14:
418:
245:
239:
332:Key:CGVWPQOFHSAKRR-NDEPHWFRSA-N
488:Drugs not assigned an ATC code
251:
233:
1:
441:. You can help Knowledge by
396:Status of Vertex development
77:)-1-piperidine-2-carboxylate
406:AARC article about the drug
514:
413:
223:Chemical and physical data
340:
315:
295:
61:
26:
391:Article on development
375:Vertex Pharmaceuticals
373:under development by
493:Antineoplastic drugs
371:pharmaceutical drug
23:
16:Pharmaceutical drug
450:
449:
352:
351:
286:Interactive image
192:CompTox Dashboard
505:
471:
464:
457:
432:immunomodulatory
422:
415:
401:PSLgroup article
348:
347:
288:
268:
253:
247:
241:
235:
215:
214:
200:
198:
183:
163:
143:
123:
113:
112:
98:
31:
24:
22:
513:
512:
508:
507:
506:
504:
503:
502:
478:
477:
476:
475:
411:
387:
343:
341:
336:
333:
328:
323:
322:
311:
308:
303:
302:
291:
266:
256:
250:
244:
238:
218:
194:
186:
166:
146:
126:
109:
101:
81:
78:
69:
68:
52:
17:
12:
11:
5:
511:
509:
501:
500:
495:
490:
480:
479:
474:
473:
466:
459:
451:
448:
447:
428:antineoplastic
423:
409:
408:
403:
398:
393:
386:
385:External links
383:
379:ovarian cancer
377:to help treat
350:
349:
338:
337:
335:
334:
331:
329:
326:
318:
317:
316:
313:
312:
310:
309:
306:
298:
297:
296:
293:
292:
290:
289:
281:
279:
271:
270:
264:
258:
257:
254:
248:
242:
236:
231:
225:
224:
220:
219:
217:
216:
208:DTXSID50893944
203:
201:
188:
187:
185:
184:
176:
174:
168:
167:
165:
164:
156:
154:
148:
147:
145:
144:
136:
134:
128:
127:
125:
124:
116:
114:
103:
102:
100:
99:
91:
89:
83:
82:
80:
79:
72:
64:
63:
62:
59:
58:
54:
53:
51:
50:
46:
44:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
510:
499:
496:
494:
491:
489:
486:
485:
483:
472:
467:
465:
460:
458:
453:
452:
446:
444:
440:
437:article is a
436:
433:
429:
424:
421:
417:
412:
407:
404:
402:
399:
397:
394:
392:
389:
388:
384:
382:
380:
376:
372:
368:
364:
360:
356:
346:
339:
330:
325:
321:
314:
305:
301:
294:
287:
283:
282:
280:
277:
272:
265:
263:
259:
232:
230:
226:
221:
213:
209:
205:
204:
202:
193:
189:
182:
178:
177:
175:
173:
169:
162:
158:
157:
155:
153:
149:
142:
138:
137:
135:
133:
129:
122:
118:
117:
115:
108:
104:
97:
93:
92:
90:
88:
84:
76:
71:
67:
60:
55:
48:
47:
45:
43:
39:
36:Clinical data
34:
30:
25:
443:expanding it
425:
410:
366:
358:
354:
353:
342:
181:ChEMBL350775
74:
365:, codename
269: g·mol
96:174254-13-8
57:Identifiers
482:Categories
274:3D model (
262:Molar mass
161:9WQP0L619L
132:ChemSpider
87:CAS Number
66:IUPAC name
355:Biricodar
21:Biricodar
369:) was a
345:(verify)
42:ATC code
267:603.716
229:Formula
141:2301309
121:3037617
107:PubChem
367:VX-710
300:SMILES
172:ChEMBL
426:This
359:incel
320:InChI
276:JSmol
439:stub
435:drug
152:UNII
49:none
430:or
363:INN
357:or
197:EPA
111:CID
484::
243:41
237:34
470:e
463:t
456:v
445:.
361:(
278:)
255:7
252:O
249:3
246:N
240:H
234:C
199:)
195:(
75:S
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
